[go: up one dir, main page]

EA200701086A1 - Производные изоксазола, их фармацевтические композиции и способ лечения невропатической боли - Google Patents

Производные изоксазола, их фармацевтические композиции и способ лечения невропатической боли

Info

Publication number
EA200701086A1
EA200701086A1 EA200701086A EA200701086A EA200701086A1 EA 200701086 A1 EA200701086 A1 EA 200701086A1 EA 200701086 A EA200701086 A EA 200701086A EA 200701086 A EA200701086 A EA 200701086A EA 200701086 A1 EA200701086 A1 EA 200701086A1
Authority
EA
Eurasian Patent Office
Prior art keywords
neuropathic pain
izokazozola
derivatives
treatment
pharmaceutical compositions
Prior art date
Application number
EA200701086A
Other languages
English (en)
Other versions
EA013905B1 (ru
Inventor
Мауро Наполетано
Ерманно Моригги
Original Assignee
Замбон С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Замбон С.П.А. filed Critical Замбон С.П.А.
Publication of EA200701086A1 publication Critical patent/EA200701086A1/ru
Publication of EA013905B1 publication Critical patent/EA013905B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к новому фармацевтическому применению производных изоксазола или его фармацевтически приемлемых солей для получения лекарственного средства, являющегося эффективным для лечения невропатической боли.
EA200701086A 2004-11-16 2005-11-14 Производные изоксазола, их фармацевтические композиции и способ лечения невропатической боли EA013905B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002187A ITMI20042187A1 (it) 2004-11-16 2004-11-16 Derivati isossazolici per allievare il dolore neiropatico
PCT/EP2005/055940 WO2006053860A1 (en) 2004-11-16 2005-11-14 Isoxazolic derivative to relieve neuropathic pain

Publications (2)

Publication Number Publication Date
EA200701086A1 true EA200701086A1 (ru) 2007-12-28
EA013905B1 EA013905B1 (ru) 2010-08-30

Family

ID=35840677

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200701086A EA013905B1 (ru) 2004-11-16 2005-11-14 Производные изоксазола, их фармацевтические композиции и способ лечения невропатической боли

Country Status (16)

Country Link
US (1) US7834040B2 (ru)
EP (1) EP1817029B1 (ru)
AT (1) ATE442848T1 (ru)
CA (1) CA2586664C (ru)
CY (1) CY1110563T1 (ru)
DE (1) DE602005016711D1 (ru)
DK (1) DK1817029T3 (ru)
EA (1) EA013905B1 (ru)
ES (1) ES2331921T3 (ru)
HR (1) HRP20090592T1 (ru)
IT (1) ITMI20042187A1 (ru)
PL (1) PL1817029T3 (ru)
PT (1) PT1817029E (ru)
RS (1) RS51020B (ru)
SI (1) SI1817029T1 (ru)
WO (1) WO2006053860A1 (ru)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3864124D1 (de) * 1987-05-20 1991-09-12 Zambon Spa Isoxazole mit nootropischer wirkung.

Also Published As

Publication number Publication date
ES2331921T3 (es) 2010-01-20
EP1817029B1 (en) 2009-09-16
ITMI20042187A1 (it) 2005-02-16
EA013905B1 (ru) 2010-08-30
WO2006053860A1 (en) 2006-05-26
SI1817029T1 (sl) 2010-01-29
CA2586664C (en) 2012-09-18
DE602005016711D1 (de) 2009-10-29
CY1110563T1 (el) 2015-04-29
US20080108679A1 (en) 2008-05-08
EP1817029A1 (en) 2007-08-15
DK1817029T3 (da) 2009-12-14
PT1817029E (pt) 2009-11-20
US7834040B2 (en) 2010-11-16
HRP20090592T1 (hr) 2009-12-31
PL1817029T3 (pl) 2010-02-26
ATE442848T1 (de) 2009-10-15
RS51020B (sr) 2010-10-31
CA2586664A1 (en) 2006-05-26

Similar Documents

Publication Publication Date Title
EA200800798A1 (ru) Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
EA200970611A1 (ru) Замещенные пиразолохиназолиновые производные, способ их получения и их применение в качестве ингибиторов киназы
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
WO2007112000A3 (en) Treatment of pain
MY143795A (en) Tetrahydropyridoindole derivatives
EA200971107A1 (ru) Катехоламиновые производные, полезные для лечения болезни паркинсона
EA200800147A1 (ru) Способ получения олмесартан медоксомила
EA201270144A1 (ru) Комбинированная терапия при лечении диабета
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
WO2008070010A3 (en) Hydroxylamine derivatives for the treatment of stroke
TW200639159A (en) Treatment of pain
CR10410A (es) Carboxamidas sustituidas.
EA200501310A1 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения боли
WO2007064448A3 (en) Cancer treatment using fts and 2-deoxyglucose
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
EA200970122A1 (ru) Фармацевтически приемлемые солевые и полиморфные формы малеата флюпиртина
ATE541567T1 (de) Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten
EA200600998A1 (ru) Фармацевтическая композиция, содержащая цинк-гиалуронановый комплекс, предназначенная для лечения рассеянного склероза
WO2007144889A3 (en) Treatment of neurofibromatosis
MXPA05007253A (es) Sales novedosas de derivados anticonvulsivantes.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU